Device: dextran sulfate adsorption (DrugBank: Dextran, Sulfate)
5 diseases| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 2 | Amyotrophic lateral sclerosis | 0 |
| 62 | Paroxysmal nocturnal hemoglobinuria | 0 |
| 79 | Homozygous familial hypercholesterolemia | 1 |
| 96 | Crohn disease | 0 |
| 97 | Ulcerative colitis | 0 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02286596 (ClinicalTrials.gov) | April 2013 | 3/11/2014 | Comparisons of Two Low-density Lipoprotein Apheresis Systems in Patients With Homozygous Familial Hypercholesterolemia | Comparisons of Two Low-density Lipoprotein Apheresis Systems in Patients With Homozygous Familial Hypercholesterolemia | Homozygous Familial Hypercholesterolemia | Device: heparin-induced extracorporeal LDL precipitation;Device: dextran sulfate adsorption | Laval University | NULL | Completed | 18 Years | 60 Years | Both | 9 | N/A | Canada |